Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

Recs

0
Player Avatar pchop123 (80.22) Submitted: 1/22/2013 2:01:40 PM : Underperform Start Price: $2.28 LXRX Score: +5.15

likely dilution on the way

Featured Broker Partners


Advertisement